Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 14.52
-0.48 (-3.20%)
At close: Dec 12, 2025
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 14.4 billion as of December 12, 2025. Its market cap has increased by 707.35% in one year.
Market Cap
14.40B
Enterprise Value
12.43B
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.52
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 14.40B, a decrease of -8.20%. That is a compound annual growth rate of -1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 14.40B | 396.02% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | 3.15B | -4.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.43B |
| Hansoh Pharmaceutical Group Company | 257.41B |
| JD Health International | 188.25B |
| Innovent Biologics | 143.10B |
| WuXi Biologics | 138.62B |
| Sino Biopharmaceutical | 121.03B |
| Akeso | 107.59B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.12B |